| Product Code: ETC10797679 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Pharmacovigilance Software Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Pharmacovigilance Software Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Pharmacovigilance Software Market - Industry Life Cycle |
3.4 Israel Pharmacovigilance Software Market - Porter's Five Forces |
3.5 Israel Pharmacovigilance Software Market Revenues & Volume Share, By Software Type, 2021 & 2031F |
3.6 Israel Pharmacovigilance Software Market Revenues & Volume Share, By Functionality, 2021 & 2031F |
3.7 Israel Pharmacovigilance Software Market Revenues & Volume Share, By Deployment Mode, 2021 & 2031F |
3.8 Israel Pharmacovigilance Software Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Israel Pharmacovigilance Software Market Revenues & Volume Share, By Key Feature, 2021 & 2031F |
4 Israel Pharmacovigilance Software Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing regulatory requirements related to drug safety and adverse event reporting |
4.2.2 Growing focus on patient safety and drug efficacy |
4.2.3 Rising adoption of pharmacovigilance software by pharmaceutical companies for efficient adverse event management |
4.3 Market Restraints |
4.3.1 High implementation costs of pharmacovigilance software solutions |
4.3.2 Concerns regarding data security and privacy in pharmacovigilance activities |
5 Israel Pharmacovigilance Software Market Trends |
6 Israel Pharmacovigilance Software Market, By Types |
6.1 Israel Pharmacovigilance Software Market, By Software Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Pharmacovigilance Software Market Revenues & Volume, By Software Type, 2021 - 2031F |
6.1.3 Israel Pharmacovigilance Software Market Revenues & Volume, By Adverse Event Reporting Software, 2021 - 2031F |
6.1.4 Israel Pharmacovigilance Software Market Revenues & Volume, By Drug Safety Database, 2021 - 2031F |
6.1.5 Israel Pharmacovigilance Software Market Revenues & Volume, By Risk Management Software, 2021 - 2031F |
6.1.6 Israel Pharmacovigilance Software Market Revenues & Volume, By Literature Review Tools, 2021 - 2031F |
6.1.7 Israel Pharmacovigilance Software Market Revenues & Volume, By Periodic Safety Update Reporting (PSUR), 2021 - 2031F |
6.2 Israel Pharmacovigilance Software Market, By Functionality |
6.2.1 Overview and Analysis |
6.2.2 Israel Pharmacovigilance Software Market Revenues & Volume, By Data Management, 2021 - 2031F |
6.2.3 Israel Pharmacovigilance Software Market Revenues & Volume, By Signal Detection, 2021 - 2031F |
6.2.4 Israel Pharmacovigilance Software Market Revenues & Volume, By Compliance Monitoring, 2021 - 2031F |
6.2.5 Israel Pharmacovigilance Software Market Revenues & Volume, By Regulatory Reporting, 2021 - 2031F |
6.2.6 Israel Pharmacovigilance Software Market Revenues & Volume, By Workflow Automation, 2021 - 2031F |
6.3 Israel Pharmacovigilance Software Market, By Deployment Mode |
6.3.1 Overview and Analysis |
6.3.2 Israel Pharmacovigilance Software Market Revenues & Volume, By Cloud-Based, 2021 - 2031F |
6.3.3 Israel Pharmacovigilance Software Market Revenues & Volume, By Web-Based, 2021 - 2031F |
6.3.4 Israel Pharmacovigilance Software Market Revenues & Volume, By On-Premise, 2021 - 2031F |
6.3.5 Israel Pharmacovigilance Software Market Revenues & Volume, By SaaS, 2021 - 2031F |
6.3.6 Israel Pharmacovigilance Software Market Revenues & Volume, By Hybrid, 2021 - 2031F |
6.4 Israel Pharmacovigilance Software Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Israel Pharmacovigilance Software Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.4.3 Israel Pharmacovigilance Software Market Revenues & Volume, By Biotech Firms, 2021 - 2031F |
6.4.4 Israel Pharmacovigilance Software Market Revenues & Volume, By Contract Research Organizations (CROs), 2021 - 2031F |
6.4.5 Israel Pharmacovigilance Software Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.4.6 Israel Pharmacovigilance Software Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5 Israel Pharmacovigilance Software Market, By Key Feature |
6.5.1 Overview and Analysis |
6.5.2 Israel Pharmacovigilance Software Market Revenues & Volume, By Automated Case Processing, 2021 - 2031F |
6.5.3 Israel Pharmacovigilance Software Market Revenues & Volume, By AI & ML Integration, 2021 - 2031F |
6.5.4 Israel Pharmacovigilance Software Market Revenues & Volume, By Multi-Channel Integration, 2021 - 2031F |
6.5.5 Israel Pharmacovigilance Software Market Revenues & Volume, By Real-Time Reporting, 2021 - 2031F |
6.5.6 Israel Pharmacovigilance Software Market Revenues & Volume, By Integrated Pharmacovigilance Systems, 2021 - 2031F |
7 Israel Pharmacovigilance Software Market Import-Export Trade Statistics |
7.1 Israel Pharmacovigilance Software Market Export to Major Countries |
7.2 Israel Pharmacovigilance Software Market Imports from Major Countries |
8 Israel Pharmacovigilance Software Market Key Performance Indicators |
8.1 Percentage increase in the number of adverse events reported and managed using the software |
8.2 Reduction in time taken to analyze and report adverse events |
8.3 Number of regulatory compliance requirements met through the software |
8.4 Increase in the efficiency of signal detection and risk assessment |
8.5 Improvement in overall drug safety monitoring and surveillance |
9 Israel Pharmacovigilance Software Market - Opportunity Assessment |
9.1 Israel Pharmacovigilance Software Market Opportunity Assessment, By Software Type, 2021 & 2031F |
9.2 Israel Pharmacovigilance Software Market Opportunity Assessment, By Functionality, 2021 & 2031F |
9.3 Israel Pharmacovigilance Software Market Opportunity Assessment, By Deployment Mode, 2021 & 2031F |
9.4 Israel Pharmacovigilance Software Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Israel Pharmacovigilance Software Market Opportunity Assessment, By Key Feature, 2021 & 2031F |
10 Israel Pharmacovigilance Software Market - Competitive Landscape |
10.1 Israel Pharmacovigilance Software Market Revenue Share, By Companies, 2024 |
10.2 Israel Pharmacovigilance Software Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here